GlassScriptPhysician profile
Natalie K Moore
NPI 1568518173
$708.79
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $108 · 2022: $18.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $206.61 | 2019-2022 | |
| Avion Pharmaceuticals | $69.62 | 2019-2020 | |
| Duchesnay USA Incorporated | $58.14 | 2019 | |
| Mission Pharmacal Company | $57.04 | 2019 | |
| Lupin INC. | $56.46 | 2019-2020 | |
| Pfizer INC. | $47.47 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $41.87 | 2019-2020 | |
| Therapeuticsmd, INC. | $26.15 | 2019-2020 | |
| Roche Diagnostics Corporation | $26.08 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.32 | 2019 | |
| Allergan, INC. | $24.03 | 2019-2020 | |
| Coopersurgical, INC. | $21.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.51 | 2020 | |
| Hologic Sales and Service, LLC | $16.16 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.